1. Home
  2. ILMN vs H Comparison

ILMN vs H Comparison

Compare ILMN & H Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • H
  • Stock Information
  • Founded
  • ILMN 1998
  • H 1957
  • Country
  • ILMN United States
  • H United States
  • Employees
  • ILMN N/A
  • H N/A
  • Industry
  • ILMN Medical Specialities
  • H Hotels/Resorts
  • Sector
  • ILMN Health Care
  • H Consumer Discretionary
  • Exchange
  • ILMN Nasdaq
  • H Nasdaq
  • Market Cap
  • ILMN 15.3B
  • H 13.9B
  • IPO Year
  • ILMN 2000
  • H 2009
  • Fundamental
  • Price
  • ILMN $96.70
  • H $145.27
  • Analyst Decision
  • ILMN Buy
  • H Buy
  • Analyst Count
  • ILMN 15
  • H 18
  • Target Price
  • ILMN $124.27
  • H $152.56
  • AVG Volume (30 Days)
  • ILMN 1.7M
  • H 825.7K
  • Earning Date
  • ILMN 11-03-2025
  • H 11-06-2025
  • Dividend Yield
  • ILMN N/A
  • H 0.41%
  • EPS Growth
  • ILMN N/A
  • H N/A
  • EPS
  • ILMN 7.91
  • H 4.36
  • Revenue
  • ILMN $4,284,000,000.00
  • H $3,218,000,000.00
  • Revenue This Year
  • ILMN N/A
  • H $120.48
  • Revenue Next Year
  • ILMN $2.74
  • H $4.61
  • P/E Ratio
  • ILMN $12.21
  • H $33.46
  • Revenue Growth
  • ILMN N/A
  • H N/A
  • 52 Week Low
  • ILMN $68.70
  • H $102.43
  • 52 Week High
  • ILMN $156.66
  • H $168.20
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 47.19
  • H 54.60
  • Support Level
  • ILMN $95.77
  • H $143.30
  • Resistance Level
  • ILMN $103.00
  • H $148.99
  • Average True Range (ATR)
  • ILMN 3.53
  • H 3.32
  • MACD
  • ILMN 0.02
  • H 0.32
  • Stochastic Oscillator
  • ILMN 48.30
  • H 61.07

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About H Hyatt Hotels Corporation

Hyatt is an operator of owned (3% of total rooms) and managed and franchised (97%) properties across about 30 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 63% Americas, 15% rest of world, and 22% Asia-Pacific.

Share on Social Networks: